Christopher E. Martin

Affiliations: 
Shanghai Institute of Organic Chemistry, PR China 
Area:
organic chemistry
Google:
"Christopher Martin"
Mean distance: 8.4
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Broecker F, Wegner E, Seco BMS, et al. (2019) Synthetic Oligosaccharide-based Vaccines Protect Mice from Clostridioides difficile Infections. Acs Chemical Biology
Geissner A, Reinhardt A, Rademacher C, et al. (2019) Microbe-focused glycan array screening platform. Proceedings of the National Academy of Sciences of the United States of America
Lisboa MP, Khan N, Martin C, et al. (2017) Semisynthetic glycoconjugate vaccine candidate against Streptococcus pneumoniae serotype 5. Proceedings of the National Academy of Sciences of the United States of America
Broecker F, Martin CE, Wegner E, et al. (2016) Synthetic Lipoteichoic Acid Glycans Are Potential Vaccine Candidates to Protect from Clostridium difficile Infections. Cell Chemical Biology
Broecker F, Hanske J, Martin CE, et al. (2016) Multivalent display of minimal Clostridium difficile glycan epitopes mimics antigenic properties of larger glycans. Nature Communications. 7: 11224
Möginger U, Resemann A, Martin CE, et al. (2016) Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites. Scientific Reports. 6: 20488
Zacco E, Anish C, Martin CE, et al. (2015) A Self-Assembling Peptide Scaffold for the Multivalent Presentation of Antigens. Biomacromolecules. 16: 2188-97
Bröcker F, Martin C, Hanske J, et al. (2014) Deciphering Glycan-Antibody Interactions: towards a Carbohydrate-based Vaccine against Clostridium difficile Glycobiology. 1129-1129
Anish C, Martin CE, Wahlbrink A, et al. (2013) Immunogenicity and diagnostic potential of synthetic antigenic cell surface glycans of leishmania Acs Chemical Biology. 8: 2412-2422
Martin CE, Broecker F, Eller S, et al. (2013) Glycan arrays containing synthetic Clostridium difficile lipoteichoic acid oligomers as tools toward a carbohydrate vaccine Chemical Communications. 49: 7159-7161
See more...